Skip to content
- Research shows that the COVID virus increases resistance to antiviral treatmentsNewsweek
- COVID antiviral trials: emerging resistance mutations rare, Paxlovid awareness lowUniversity of Minnesota Twin Cities
- The COVID-19 virus can develop drug resistance – but not often and not for longIFLScience
- Emergence of transmissible SARS-CoV-2 variants with reduced susceptibility to antiviral drugs in immunocompromised patients with persistent infectionsNature.com
- Antiviral resistant variants of SARS-CoV-2 can emerge in people with weakened immune systemsWeill Cornell Medicine Newsroom
